ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,072.40
-0.24%
다우존스 지수
39,869.38
-0.10%
Bitcoin
65,407.54
-1.29%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) 뉴스

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:NBY
일자시간출처헤드라인심볼기업
2024/05/1321:30Business WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/05/1005:05Business WireNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/05/0721:00Business WireNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/05/0319:50Business WireNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
2024/04/2219:57Business WireNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/04/2007:00Business WireNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/04/1719:59Business WireNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/03/2705:05Business WireNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/03/2607:38Business WireNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
2024/03/1421:00Business WireNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
2024/02/1504:52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
2024/02/0701:52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
2024/01/3023:00Business WireNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/01/1022:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/01/0923:15Business WireNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkAMEX:NBYNovaBay Pharmaceuticals Inc New
2024/01/0501:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/12/2121:58Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/12/1206:32Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/12/0620:50Business WireNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/11/1006:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
2023/11/1006:05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/11/0219:50Business WireNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
2023/10/1121:00Business WireNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/10/0219:50Business WireNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/09/2122:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/09/1421:00Business WireNovaBay Pharmaceuticals Announces Commercial Launch of Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/09/1121:00Business WireNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/08/1105:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
2023/08/1105:05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
2023/08/0905:05Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
 검색 관련기사 보기:AMEX:NBY

최근 히스토리

CCOM
US30
US 30
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
NYSE
AXP
American Express
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유